Health and Science

Purdue’s 1996-2002 marketing plans for OxyContin, which Kaiser Health News made public this year for the first time, offer an unprecedented look at how that company spent millions of dollars to push opioids for growing legions of pain sufferers. Some of those drugmakers’ sales promotions downplayed or ignored the risks of taking opioids, or made false claims about their safety, federal regulators have asserted in warning letters to the companies. A wave of lawsuits demanding reimbursement and accountability for the opioid crisis now ravaging communities has heightened awareness about how and when drug makers realized the potential dangers of their products. more »

"We’ve recently become aware of a growing number of manufacturers marketing “vaginal rejuvenation” devices to women and claiming these procedures will treat conditions and symptoms related to menopause, urinary incontinence or sexual function. The procedures use lasers and other energy-based devices to destroy or reshape vaginal tissue. These products have serious risks and don’t have adequate evidence to support their use for these purposes. We are deeply concerned women are being harmed." more »

The authors stress that rising temperature and climate change should not be viewed as direct motivations for suicide. Instead, they point out that temperature and climate may increase the risk of suicide by affecting the likelihood that an individual situation leads to an attempt at self-harm. “Hotter temperatures are clearly not the only, nor the most important, risk factor for suicide,” Burke emphasized. “But our findings suggest that warming can have a surprisingly large impact on suicide risk, and this matters for both our understanding of mental health as well as for what we should expect as temperatures continue to warm.” more »

“What we’re seeing is just like what happened with opioids in the 1990s. It really does begin with overprescribing. Liberal therapeutic use of drugs in a medical setting tends to normalize their use. People start to think they’re safe and, because they make them feel good, it doesn’t matter where they get them or how many they use ... We have this whole infrastructure set up now to prevent overprescribing of opioids and address the need for addiction treatment, said Dr. Anna Lembke, a researcher and addiction specialist at Stanford University. “We need to start making benzos part of that.” more »